Drug Type Small molecule drug |
Synonyms MD |
Target |
Action antagonists |
Mechanism GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Menopausal symptoms | Preclinical | China | 01 Jan 2026 | |
| Breast Cancer | Preclinical | China | 01 Oct 2025 |





